Gasser Elizabeth Anne
- SEC CIK
- 0001866283
No open-market purchases or sales filed in the past year.
Current role at each company
- TNDM Tandem Diabetes Care IncEVP, Chief Strategy Officeras of Aug 18, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Gasser Elizabeth Anne as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 29, 2021 (view filing) | Dec 27 | 2 days | Gasser Elizabeth AnneEVP, Chief Strategy Officer | SSale | −1.08K | $151.36 | −$164.1K | −71.6%431 after | 2 lots |
| Dec 9, 2021 (view filing) | Dec 7 | 2 days | Gasser Elizabeth AnneEVP, Chief Strategy Officer | SSale | −1.08K | $140.00 | −$151.6K | −71.5%431 after | |
| Nov 5, 2021 (view filing) | Nov 3 | 2 days | Gasser Elizabeth AnneEVP, Chief Strategy Officer | SSale | −21.8K | $140.02 | −$3.05M | −98.9%243 after |